ArticlePharmaceutics2025

DST-3, a Novel Modified Cryptotanshinone, Protects Against Pulmonary Fibrosis via Inhibiting STAT3/Smad Signaling Pathway and Improves Bioavailability.

Ruoqing Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.